Abstract:Classical homocystinuria is a rare disease caused by mutations in cystathionine β-synthase (CBS) gene (OMIM 613381). CBS catalyzes the first step of the transsulfuration pathway that converts homocysteine (Hcy) into cystathionine (Cysta) via a number of co-substrates and mechanisms. Formation of Cysta by condensation of Hcy and cysteine (Cys) produces a molar equivalent of hydrogen sulfide (H2S). H2S plays important roles in cognitive and vascular functions. Clinically, patients with CBS deficiency present with vascular, ocular, neurological and skeletal impairments. Biochemically, CBS deficiency manifests with elevated Hcy and reduced concentration of Cysta in plasma and urine. A number of pathogenic variants of human CBS have been characterized by their residual enzymatic activity, but very few studies have examined H2S production by pathogenic CBS variants, possibly due to technical hurdles in H2S detection and quantification. We describe a method for the real-time, continuous quantification of H2S formed by wild-type and pathogenic variants of human recombinant CBS, as well as by fibroblast extracts from healthy controls and patients diagnosed with CBS deficiency. The method takes advantage of the specificity and high affinity of hemoglobin I of the clam Lucina pectinata toward H2S and is based on UV-visible spectrophotometry. Comparison with the gold-standard, end-point H2S quantification method employing monobromobimane, as well as correlations with CBS enzymatic activity determined by LC-MS/MS showed agreement and correlation, and permitted the direct, time-resolved determination of H2S production rates by purified human recombinant CBS and by CBS present in fibroblast extracts. Rates of H2S production were highest for wild-type CBS, and lower for pathogenic variants. This method enables the examination of structural determinants of CBS that are important for H2S production and its possible relevance to the clinical outcome of patients.

Biochemical and structural impact of two novel missense mutations in cystathionine beta-synthase gene associated with homocystinuria

Homocystinuria In A Family With Novel Cystathionine Beta Synthase Gene Mutations

Pathogenic Homocystinuria-Associated T236N Mutation Dramatically Alters the Biochemical Properties of Cystathionine Beta-Synthase Protein

Targeting Cystathionine Beta-Synthase Misfolding in Homocystinuria by Small Ligands: State of the Art and Future Directions

Cellular turnover and degradation of the most common missense cystathionine beta‐synthase variants causing homocystinuria

Potential Pharmacological Chaperones for Cystathionine Beta-Synthase-Deficient Homocystinuria

Lipid, Oxidative and Inflammatory Profile and Alterations in the Enzymes Paraoxonase and Butyrylcholinesterase in Plasma of Patients with Homocystinuria Due CBS Deficiency: The Vitamin B12 and Folic Acid Importance

Mechanism of action and impact of thiol homeostasis on efficacy of an enzyme replacement therapy for classical homocystinuria

Deciphering pathophysiological mechanisms underlying cystathionine beta-synthase-deficient homocystinuria using targeted metabolomics, liver proteomics, sphingolipidomics and analysis of mitochondrial function

Effect of the disease-causing R266K mutation on the heme and PLP environments of human cystathionine β-synthase

Impact of primary sequence changes on the self‐association properties of mammalian cystathionine beta‐synthase enzymes

Real-time detection of enzymatically formed hydrogen sulfide by pathogenic variants of cystathionine beta-synthase using hemoglobin I of Lucina pectinata as a biosensor

High prevalence of cerebral venous sinus thrombosis in seven Chinese patients with cystathionine β-synthase deficiency

Genetic and Pharmacological Modulation of Cellular Proteostasis Leads to Partial Functional Rescue of Homocystinuria-Causing Cystathionine-Beta Synthase Variants

Novel Compound Heterozygous CBS Mutations Cause Homocystinuria in a Han Chinese Family

Chemical chaperone rescue of mutant human cystathionine β-synthase

Homocystinuria: Therapeutic approach

Impact of missense mutations on the structure–function relationship of human succinyl-CoA synthetase using in silico analysis

Redox Regulation and Reaction Mechanism of Human Cystathionine-Beta-synthase: a PLP-dependent Hemesensor Protein.

Altered gene expression in liver from a murine model of hyperhomocysteinemia

Asymmetric Dimethylarginine in Homocystinuria Due to Cystathionine Β-Synthase Deficiency: Relevance of Renal Function